Literature DB >> 15138391

[Screening for diabetes in France: data from the 2000-2001 cohort of the national medical insurance system].

I Hirtzlin1, A Fagot-Campagna, I Girard-Le Gallo, N Vallier, N Poutignat, A Weill, S Le Laidier.   

Abstract

BACKGROUND: Type 2 diabetes mellitus may go undiagnosed for several Years while complications are silently developing. In France, from 2 to 3.7% of adults aged 35-65 are unaware they have diabetes. Nevertheless fasting serum glucose is a simple diagnostic test.
METHODS: We described people who underwent opportunist diabetes screening (serum glucose) within 2 Years (2000-2001). We used the administrative EPAS cohort from the employee National Health Insurance System which covers 70% of the total population in France. The data are based on reimbursements of glucose testing and hospitalization among people who did not received reimbursements of treatment for diabetes but used medical services during the 2 Years.
RESULTS: The opportunistic screening rate within 2 Years was 48.6% overall and increased with age. Among those 45 Years old or older, it was 71.2%. The screening rate was higher among women than men.
CONCLUSION: Opportunistic screening for diabetes is commonly practised in France, despite the lack of official guidelines. Several hypotheses may explain the discrepancy between common opportunist screening and high prevalence of undiagnosed diabetes: 1). undiagnosed diabetes is mostly present in people who do not use medical services; 2). opportunistic screening is not performed among the most at-risk population; 3). testing is not performed on fasting samples or results are neglected; 4). results of testing are overlooked by doctors/patients; 5). epidemiological studies based on self-report of diagnosis and only one testing overestimate undiagnosed diabetes.

Entities:  

Mesh:

Year:  2004        PMID: 15138391     DOI: 10.1016/s0398-7620(04)99033-5

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  3 in total

1.  Assessment of diabetes screening by general practitioners in France: the EPIDIA Study.

Authors:  J Cogneau; B Balkau; A Weill; F Liard; D Simon
Journal:  Diabet Med       Date:  2006-07       Impact factor: 4.359

2.  Missed opportunities for diagnosis and treatment of diabetes, hypertension, and hypercholesterolemia in a Mexican American population, Cameron County Hispanic Cohort, 2003-2008.

Authors:  Susan P Fisher-Hoch; Kristina P Vatcheva; Susan T Laing; M Monir Hossain; M Hossein Rahbar; Craig L Hanis; H Shelton Brown; Anne R Rentfro; Belinda M Reininger; Joseph B McCormick
Journal:  Prev Chronic Dis       Date:  2012       Impact factor: 2.830

Review 3.  The burden and treatment of diabetes in France.

Authors:  Karine Chevreul; Karen Berg Brigham; Clara Bouché
Journal:  Global Health       Date:  2014-02-20       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.